| Cisplatin inhibits the progression of bladder cancer by selectively depleting G-MDSCs: A novel chemoimmunomodulating strategy | |
| Wu, Ke; Tan, Ming-Yue; Jiang, Jun-Tao; Mu, Xing-Yu; Wang, Jie-Ren; Zhou, Wen-Jie; Wang, Xiang; Li, Ming-qing; He, Yin-Yan; Liu, Zhi-Hong | |
| 刊名 | CLINICAL IMMUNOLOGY
 |
| 2018 | |
| 卷号 | 193 |
| 关键词 | Cisplatin Bladder cancer Myeloid-derived suppressor cells CD8(+) T cells Immunomodulation |
| ISSN号 | 1521-6616 |
| URL标识 | 查看原文 |
| 语种 | 英语 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/3607474 |
| 专题 | 复旦大学上海医学院 |
| 推荐引用方式 GB/T 7714 | Wu, Ke,Tan, Ming-Yue,Jiang, Jun-Tao,et al. Cisplatin inhibits the progression of bladder cancer by selectively depleting G-MDSCs: A novel chemoimmunomodulating strategy[J]. CLINICAL IMMUNOLOGY,2018,193. |
| APA | Wu, Ke.,Tan, Ming-Yue.,Jiang, Jun-Tao.,Mu, Xing-Yu.,Wang, Jie-Ren.,...&Liu, Zhi-Hong.(2018).Cisplatin inhibits the progression of bladder cancer by selectively depleting G-MDSCs: A novel chemoimmunomodulating strategy.CLINICAL IMMUNOLOGY,193. |
| MLA | Wu, Ke,et al."Cisplatin inhibits the progression of bladder cancer by selectively depleting G-MDSCs: A novel chemoimmunomodulating strategy".CLINICAL IMMUNOLOGY 193(2018). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论